The secretory burden on beta cells elicited by insulin resistance leads to their subsequent apoptosis if the burden is prolonged and this is why at the early stages, adequate glycemic control can be achieved with antidiabetic oral medication, whereas in the progression of the disease insulin will be eventually required (121). The gene discussed is INS; the disease is Insulin resistance.